Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
enGene Holdings Inc. | Director | Stock Option (Right to Buy) | 40K | Jun 15, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
NAMS | NewAmsterdam Pharma Co N.V. | Jul 16, 2024 | 0 | $0 | 3 | Jul 19, 2024 | Director |
ENGN | enGene Holdings Inc. | Jun 15, 2024 | 1 | $0 | 4 | Jun 18, 2024 | Director |
ENGN | enGene Holdings Inc. | May 15, 2024 | 0 | $0 | 3 | May 17, 2024 | Director |
FRBN | Forbion European Acquisition Corp. | Dec 9, 2021 | 0 | $0 | 3 | Dec 9, 2021 | Director |